The Determinants for the Enzyme Activity of Human Parvovirus B19 Phospholipase A2 (PLA2) and Its Influence on Cultured Cells

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Deng, Xuefeng ^a   Dong, Yanming ^a   Yi, Qianhui ^a   Huang, Yu ^a   Zhao, Dan ^a   Yang, Yongbo ^a   Tijssen, Peter ^c   Qiu, Jianming ^d   Liu, Kaiyu ^a   Li, Yi ^a,b  

^a CENTRAL CHINA NORMAL UNIVERSITY   (China)

^b Wuhan University of Bioengineering   (China)

^c INRS INSTITUT ARMAND FRAPPIER   (Canada)

^d UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHOSPHOLIPASE A2; PROTEIN VP1; TUMOR NECROSIS FACTOR ALPHA;

AMINO ACID SUBSTITUTION; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOARCHITECTURE; ENZYME ACTIVITY; HUMAN CELL CULTURE; HUMAN PARVOVIRUS B19; NONHUMAN; NUCLEOTIDE SEQUENCE; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; RESIDUE ANALYSIS; STRUCTURE ANALYSIS; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; UPREGULATION;

AMINO ACID MOTIFS; AMINO ACID SUBSTITUTION; CAPSID PROTEINS; CELL MEMBRANE; CELLS, CULTURED; CONSENSUS SEQUENCE; ENZYME ACTIVATION; ERYTHEMA INFECTIOSUM; FEMALE; HUMANS; MODELS, MOLECULAR; MUTATION; NF-KAPPA B; PARVOVIRUS B19, HUMAN; PHOSPHOLIPASES A2; PREGNANCY; PROTEIN CONFORMATION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; TRANSCRIPTIONAL ACTIVATION; TUMOR NECROSIS FACTOR-ALPHA;

MIRIDAE; PARVOVIRUS; PROKARYOTA;

EID: 84876196584     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061440     Document Type: Article

References (37)

1. Cossart YE, Field AM, Cant B, Widdows D, (1975) Parvovirus-like particles in human sera. Lancet 1: 72-73.
2. Brown KE, Young NS, (1997) Parvovirus B19 in human disease. Annu Rev Med 48: 59-67.
3. Lindblom A, Isa A, Norbeck O, Wolf S, Johansson B, et al. (2005) Slow clearance of human parvovirus B19 viremia following acute infection. Clin Infect Dis 41: 1201-1203.
4. Young NS, Brown KE, (2004) Parvovirus B19. N Engl J Med 350: 586-597.
5. Anderson MJ, Lewis E, Kidd IM, Hall SM, Cohen BJ, (1984) An outbreak of erythema infectiosum associated with human parvovirus infection. J Hyg (Lond) 93: 85-93.
6. Anderson MJ, Jones SE, Fisher-Hoch SP, Lewis E, Hall SM, et al. (1983) Human parvovirus, the cause of erythema infectiosum (fifth disease)? Lancet 1: 1378.
7. Brown KE, Young NS, (1997) Human parvovirus B19 infections in infants and children. Adv Pediatr Infect Dis 13: 101-126.
8. Schowengerdt KO, Ni J, Denfield SW, Gajarski RJ, Bowles NE, et al. (1997) Association of parvovirus B19 genome in children with myocarditis and cardiac allograft rejection: diagnosis using the polymerase chain reaction. Circulation 96: 3549-3554.
9. Moffatt S, Yaegashi N, Tada K, Tanaka N, Sugamura K, (1998) Human parvovirus B19 nonstructural (NS1) protein induces apoptosis in erythroid lineage cells. J Virol 72: 3018-3028.
10. Poole BD, Karetnyi YV, Naides SJ, (2004) Parvovirus B19-induced apoptosis of hepatocytes. J Virol 78: 7775-7783.
11. Hsu TC, Wu WJ, Chen MC, Tsay GJ, (2004) Human parvovirus B19 non-structural protein (NS1) induces apoptosis through mitochondria cell death pathway in COS-7 cells. Scand J Infect Dis 36: 570-577.
12. Moffatt S, Tanaka N, Tada K, Nose M, Nakamura M, et al. (1996) A cytotoxic nonstructural protein, NS1, of human parvovirus B19 induces activation of interleukin-6 gene expression. J Virol 70: 8485-8491.
13. Dorsch S, Liebisch G, Kaufmann B, von Landenberg P, Hoffmann JH, et al. (2002) The VP1 unique region of parvovirus B19 and its constituent phospholipase A2-like activity. J Virol 76: 2014-2018.
14. Zadori Z, Szelei J, Lacoste MC, Li Y, Gariepy S, et al. (2001) A viral phospholipase A2 is required for parvovirus infectivity. Dev Cell 1: 291-302.
15. Lu J, Zhi N, Wong S, Brown KE, (2006) Activation of synoviocytes by the secreted phospholipase A2 motif in the VP1-unique region of parvovirus B19 minor capsid protein. J Infect Dis 193: 582-590.
16. Filippone C, Zhi N, Wong S, Lu J, Kajigaya S, et al. (2008) VP1u phospholipase activity is critical for infectivity of full-length parvovirus B19 genomic clones. Virology 374: 444-452.
17. Balsinde J, Balboa MA, Insel PA, Dennis EA, (1999) Regulation and inhibition of phospholipase A2. Annu Rev Pharmacol Toxicol 39: 175-189.
18. Murakami M, Nakatani Y, Atsumi G, Inoue K, Kudo I, (1997) Regulatory functions of phospholipase A2. Crit Rev Immunol 17: 225-283.
19. Tzang BS, Tsay GJ, Lee YJ, Li C, Sun YS, et al. (2007) The association of VP1 unique region protein in acute parvovirus B19 infection and anti-phospholipid antibody production. Clin Chim Acta 378: 59-65.
20. Wu D, Marko M, Claycombe K, Paulson KE, Meydani SN, (2003) Ceramide-induced and age-associated increase in macrophage COX-2 expression is mediated through up-regulation of NF-kappa B activity. J Biol Chem 278: 10983-10992.
21. Tzang BS, Lin TM, Tsai CC, Hsu JD, Yang LC, et al. (2011) Increased cardiac injury in NZB/W F1 mice received antibody against human parvovirus B19 VP1 unique region protein. Mol Immunol 48: 1518-1524.
22. Dennis EA, (1997) The growing phospholipase A2 superfamily of signal transduction enzymes. Trends Biochem Sci 22: 1-2.
23. Drechsler MD, Obermeier I, Doring Y, Lackner KJ, Modrow S, et al. (2008) Generation of multifunctional murine monoclonal antibodies specifically directed to the VP1unique region protein of human parvovirus B19. Immunobiology 213: 511-517.
24. Li Y, Zadori Z, Bando H, Dubuc R, Fediere G, et al. (2001) Genome organization of the densovirus from Bombyx mori (BmDNV-1) and enzyme activity of its capsid. J Gen Virol 82: 2821-2825.
25. Lupescu A, Bock CT, Lang PA, Aberle S, Kaiser H, et al. (2006) Phospholipase A2 activity-dependent stimulation of Ca2+ entry by human parvovirus B19 capsid protein VP1. J Virol 80: 11370-11380.
26. Zhi N, Zadori Z, Brown KE, Tijssen P, (2004) Construction and sequencing of an infectious clone of the human parvovirus B19. Virology 318: 142-152.
27. Alter P, Rupp H, Maisch B, (2006) Activated nuclear transcription factor kappaB in patients with myocarditis and dilated cardiomyopathy-relation to inflammation and cardiac function. Biochem Biophys Res Commun 339: 180-187.
28. Chen AY, Guan W, Lou S, Liu Z, Kleiboeker S, et al. (2010) Role of erythropoietin receptor signaling in parvovirus B19 replication in human erythroid progenitor cells. J Virol 84: 12385-12396.
29. Chen AY, Zhang EY, Guan W, Cheng F, Kleiboeker S, et al. (2010) The small 11 kDa nonstructural protein of human parvovirus B19 plays a key role in inducing apoptosis during B19 virus infection of primary erythroid progenitor cells. Blood 115: 1070-1080.
30. Luo Y, Lou S, Deng X, Liu Z, Li Y, et al. (2011) Parvovirus B19 infection of human primary erythroid progenitor cells triggers ATR-Chk1 signaling, which promotes B19 virus replication. J Virol 85: 8046-8055.
31. Lou S, Luo Y, Cheng F, Huang Q, Shen W, et al. (2012) Human parvovirus B19 DNA replication induces a DNA damage response that is dispensable for cell cycle arrest at phase G2/M. J Virol 86: 10748-10758.
32. Sun Y, Chen AY, Cheng F, Guan W, Johnson FB, et al. (2009) Molecular characterization of infectious clones of the minute virus of canines reveals unique features of bocaviruses. J Virol 83: 3956-3967.
33. Canaan S, Zadori Z, Ghomashchi F, Bollinger J, Sadilek M, et al. (2004) Interfacial enzymology of parvovirus phospholipases A2. J Biol Chem 279: 14502-14508.
34. Rosenfeld SJ, Yoshimoto K, Kajigaya S, Anderson S, Young NS, et al. (1992) Unique region of the minor capsid protein of human parvovirus B19 is exposed on the virion surface. J Clin Invest 89: 2023-2029.
35. Venkatakrishnan B, Yarbrough J, Domsic J, Bennett A, Bothner B, et al. (2013) Structure and dynamics of Adeno-Associated Virus serotype 1 VP1-unique N-terminal domain and its role in capsid trafficking. Journal of Virology.
36. Lunardi C, Tinazzi E, Bason C, Dolcino M, Corrocher R, et al. (2008) Human parvovirus B19 infection and autoimmunity. Autoimmun Rev 8: 116-120.
37. Bemelmans MH, van Tits LJ, Buurman WA, (1996) Tumor necrosis factor: function, release and clearance. Crit Rev Immunol 16: 1-11.